Back to Search Start Over

Stroke prevention: Learning from the master (and COMMANDER)

Authors :
Santulli, Gaetano
Source :
Science Translational Medicine; September 2018, Vol. 10 Issue: 459
Publication Year :
2018

Abstract

Adding rivaroxaban to standard therapy in patients with heart failure and no atrial fibrillation did not show any beneficial effect on death risk.

Details

Language :
English
ISSN :
19466234 and 19466242
Volume :
10
Issue :
459
Database :
Supplemental Index
Journal :
Science Translational Medicine
Publication Type :
Periodical
Accession number :
ejs46564282
Full Text :
https://doi.org/10.1126/scitranslmed.aav0340